Achieve a 98% primary fascial closure on intentionally left-open abdomens
When a patient requires open abdomen treatment, facilitating early
aggressive closure without increasing complications is crucial.
aggressive closure without increasing complications is crucial.
Guidelines show that prompt and safe prevention of fascial retraction with negative pressure wound therapy and a traction device can improve outcomes in open abdomen management.
Non-Invasive & 100% Compatible with AbThera
Being external, AbClo protects fascial integrity while allowing staff-managed bedside monitoring.
Preventative Care Mitigates Fascial Retraction and Closure Complications
Reduce the risk of infection, fistulas and hernias during open abdomen management by preventing fascial retraction and promoting closure.

Testimonials
We saw positive patient impacts almost immediately once we began using the AbClo. In addition, we save considerable hard and soft costs and our physicians enjoyed using the AbClo device. Using the AbClo is not only improving our patient care but freeing up significant resources when we need them the most.

The important part for me was I didn't know which patient was going to have that prolonged open abdomen. So this was that insurance policy for me that [...]I'm not losing ground, so if I can't get that patient back until the next day, it's gonna be okay.

The AbClo device resulted in a primary myofascial closure rate of 98%. Our findings suggest that a non-invasive, preemptive, approach to fascial reapproximation could have a positive impact in preventing lateralization and contraction of the abdominal wall in OA patients.

AbClo dramatically improved our closure rate for open abdomen patients. It was easy to use and was easily integrated into my current treatment methods for open abdomen patients. AbClo’s use resulted in better outcomes for my patients.

AbClo has provided us with an important additional non-invasive approach to aggressive facial closure for our OA cases in our trauma service. Our ability to manage the reapproximation of the OA cases is a significant advantage that may avoid using more invasive alternative devices that are currently available.

It's completely external. I don't have bands going in the patient and then out of the patient... When we take these patients back for closure, they don't have holes in the fascia. They don't have that fascial damage [...] It's clean and much more precise.

AbClo allowed us to successfully close when we needed.

This is a completely non-invasive device that allows the surgeon to gain reapproximation of the abdominal wall... And an interesting point that we have to highlight here is that the device moves the entire abdominal wall and fascia, not only the skin.

The AbClo device is a game-changer. Patients consistently have good outcomes. What's really
impressive is how it helps fascia on larger patients close faster. It's made a significant difference
in our practice and patient care.

After a review of AbClo, Vizient's client council agreed this technology offers a unique benefit over other products available in the market today and recommended it for an Innovative Technology contract. We are pleased to award this new contract to InventoRR MD Inc.

The first twenty cases, there was a bit of a learning curve... But of the fifteen patients who returned to the OR with intent to close, AbClo was in place nearly the entire time... We obtained 100% primary fascial closure rate in all of our patients.

This is a completely non-invasive device that allows the surgeon to gain reapproximation of the abdominal wall... And an interesting point that we have to highlight here is that the device moves the entire abdominal wall and fascia, not only the skin.

We were very excited when introduced to the AbClo because of the unique non-invasive approach. We were very happy to note that the pressure along the entirety of the wound edge was indeed uniform, and was able to bring all levels of the abdomen together without any suture pullout risk, and without any damage to the fascia or tissues. There's been no identifiable disadvantage of using the AbClo.

Why AbClo?
Non-invasively manage and promote closure of open abdomen with our FDA Licensed Device.
Easy to Apply
Our intuitive device is easy to use and can be managed at the patient’s bedside. It integrates easily into existing care paths and procedures.
Better Patient Experience
We prioritize patient experience by providing a non-invasive solution that minimizes additional skin damage and complications.
Increase Hospital Efficiency
AbClo streamlines the treatment process, saving time and resources while delivering optimal results.
Insights
Latest News
Explore the most recent developments and advancements with AbClo.

